Health Care & Life Sciences » Pharmaceuticals | Jiangsu Nhwa Pharmaceutical Co. Ltd.

Jiangsu Nhwa Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
172,485.70
221,254.10
255,281.40
301,685.80
375,252.00
519,161.50
Depreciation, Depletion & Amortization
36,846.60
43,730.90
49,579.90
49,966.10
60,253.80
79,689.90
Other Funds
-
-
536,580.70
11,636.80
-
74,334.30
Funds from Operations
220,567.90
277,250.60
316,639.50
373,490.00
456,305.00
671,584.30
Changes in Working Capital
43,239.90
136,461.50
129,467.20
96,348.60
12,531.10
267,059.60
Net Operating Cash Flow
177,328.00
140,789.10
187,172.30
277,141.40
443,774.00
404,524.70
Capital Expenditures
103,628.20
261,601.70
216,630.70
102,221.30
166,006.80
Sale of Fixed Assets & Businesses
195.00
368.90
187.80
1,963.30
24,121.50
Purchase/Sale of Investments
14,000.00
14,000.00
-
137,617.80
216,000.00
Net Investing Cash Flow
117,433.30
247,232.80
216,443.00
237,875.80
295,872.40
Cash Dividends Paid - Total
18,720.00
18,018.00
23,587.20
29,110.00
37,843.00
Issuance/Reduction of Debt, Net
8,300.00
93,000.00
134,000.00
25,000.00
30,829.20
Net Financing Cash Flow
27,020.00
74,982.00
378,993.50
15,746.80
68,672.20
Net Change in Cash
32,639.30
31,513.90
349,787.00
23,693.70
79,309.60
Free Cash Flow
73,699.70
120,812.60
29,458.40
174,920.10
277,767.10
Deferred Taxes & Investment Tax Credit
1,268.90
2,908.60
4,779.60
3,878.40
3,841.20
1,601.40
Other Sources
-
-
-
-
62,012.90
Exchange Rate Effect
235.30
52.30
64.20
174.90
80.30

About Jiangsu Nhwa Pharmaceutical Co.

View Profile
Address
En Hua Building
Xuzhou Jiangsu 221009
China
Employees -
Website http://www.nhwa-group.com
Updated 07/08/2019
Jiangsu Nhwa Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products. Its focuses on central nervous system products. The company produces anesthesia, nervous system disease treatments, and nerve medicine raw materials.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.